Albumin Is Fastest Growing Segment Fueling The Growth Of Blood Plasma Derivatives Market
The global Blood Plasma
Derivatives Market is estimated to be valued at US$ 44.33 Bn in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market Overview:
Blood plasma derivatives are proteins made from blood plasma, which is the
liquid component of blood that remains after removing red and white blood
cells. The key derivatives include albumin, immunoglobulin, coagulation
factors, hyperimmune globulins, and other specialty proteins. These proteins
play a crucial role in maintaining homeostasis, immunity, and coagulation.
Market key trends:
The demand for albumin is rising significantly driven by its wide applications
in treating various respiratory diseases, shock or trauma, burns, liver
diseases, and other chronic illnesses. Albumin helps maintain adequate blood
volume and pressure for circulatory functions. It is commonly used during major
surgeries to replace lost fluids and nutrients. The growing prevalence of
chronic and lifestyle diseases along with aging population is expected to
propel the demand for albumin and fuel the growth of the blood plasma
derivatives market over the forecast period.
Segment Analysis
The global blood plasma derivatives market is segmented into albumin,
immunoglobulins, coagulation factor concentrates, and protease inhibitors.
Among these, the immunoglobulins segment accounts for the largest market share
of over 35% in 2023. Immunoglobulins are becoming the core treatment for
various primary immunodeficiency disorders and are dominating the market due to
their widespread applications in autoimmune disorders and infections.
Key Takeaways
The Global
Blood Plasma Derivatives Market Size is expected to witness high
growth, exhibiting CAGR of 9.3% over
the forecast period, due to increasing prevalence of immunodeficiency and
autoimmune disorders.
Regional Analysis
North America dominates the global blood plasma derivatives market with over
45% share in 2023 and is expected to retain its position over the forecast
period. This is attributed to the high adoption of immunoglobulins and albumin
for various applications in the region. Asia Pacific is expected to witness the
fastest growth over 2023-2030 owing to increasing healthcare infrastructure
coupled with growing medical tourism in countries such as India, China, and
Japan.
Key Players
Key players operating in the blood plasma derivatives market are Shire Plc.,
CSL Limited, Octapharma AG, LFB S.A., Biotest AG, Grifols, S.A., SK Plasma Co.,
Ltd., Baxter International Inc., Green Cross Corporation, and Fusion Health
Care Pvt. Ltd., among others. Shire Plc. is expected to lead the market over
2023-2030, supported by its diverse immunoglobulin portfolio and wide
geographic footprint.
Read
More: https://www.ukwebwire.com/blood-plasma-derivatives-market-size-share-and-growth-forecast-2023-2030/
Comments
Post a Comment